Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

612
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
612

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expanding the Discussion on Pneumocystis jirovecii Pneumonia Prophylaxis in Non-HIV Immunocompromised Adults.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Parasitic infections in solid organ transplant.

The American journal of the medical sciences·2026
Same author

Clinical Characteristics and Outcomes of Cytomegalovirus DNAemia in Non-HIV-Infected and Non-Transplant Patients: A Propensity Score-Matched Analysis.

Pathogens (Basel, Switzerland)·2026
Same author

Heart Failure Incidence and Risk Factors in U.S. Adults Receiving Bezlotoxumab: A Large Database Analysis.

Infectious disease reports·2026
Same author

Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.

Nature microbiology·2026
Same author

Epidemiology and Outcomes of Sporotrichosis: A Descriptive Real-World Analysis From a Global Cohort.

Mycoses·2026
Same journal

The balance between a new Antibiotic and Non-antibiotic Alternatives for the treatment and prevention of uncomplicated Urinary Tract Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

2.2K

State-of-the-Art Review: Chagas Disease-an Enduring Challenge.

Nelson Iván Agudelo Higuita1,2, Andrés F Henao-Martínez3, Marjorie Vieira Batista4

  • 1Department of Medicine, Division of Infectious Diseases, University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|February 25, 2026
PubMed
Summary
This summary is machine-generated.

Chagas disease, caused by Trypanosoma cruzi, is a major neglected tropical disease in the Americas. This review details its pathogenesis, diagnosis, and care, especially for immunosuppressed patients.

Keywords:
T. cruziChagas diseaseneglected tropical diseasesreactivationtransplantation

More Related Videos

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.9K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.7K

Related Experiment Videos

Last Updated: Feb 28, 2026

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

2.2K
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.9K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.7K

Area of Science:

  • Tropical Medicine
  • Infectious Diseases
  • Parasitology

Background:

  • Chagas disease is a significant neglected tropical disease in the Western Hemisphere, caused by Trypanosoma cruzi.
  • Socioeconomic factors, cultural practices, and historical inequities exacerbate its impact on impoverished rural communities in Latin America and vulnerable populations globally.
  • Trypanosoma cruzi infection presents unique challenges for healthcare systems, necessitating targeted interventions.

Purpose of the Study:

  • To review the pathogenesis of Chagas disease.
  • To examine critical aspects of patient care, including screening high-risk populations, and analyze barriers to diagnosis and treatment.
  • To provide evidence-based care concepts for immunosuppressed patients with T. cruzi infection.

Main Methods:

  • Comprehensive literature review of Chagas disease pathogenesis, clinical presentations, and management strategies.
  • Analysis of transmission pathways, host factors, disease staging, diagnostic methods, and therapeutic interventions.
  • Focus on care for immunosuppressed individuals with T. cruzi infection.

Main Results:

  • The review covers the spectrum of clinical presentations, diagnostic methodologies, and therapeutic interventions for acute and chronic Chagas disease.
  • It identifies high-risk populations for targeted screening and analyzes existing barriers to diagnosis and treatment implementation.
  • Key evidence-based care concepts for the increasingly important subset of immunosuppressed patients are provided.

Conclusions:

  • Chagas disease management requires a multifaceted approach addressing pathogenesis, socioeconomic determinants, and evolving treatment paradigms.
  • Targeted screening and overcoming diagnostic/treatment barriers are crucial for effective Chagas disease control.
  • Specialized care strategies for immunosuppressed patients are essential, reflecting advancements in managing T. cruzi infection.